Italy is one of the largest consumers of broad-spectrum agents (BSAs) in Europe. This study evaluated surgical antimicrobial prophylaxis (SAP) compliance with the Italian national guidelines and its impact on surgical site infection (SSI) risk.
Surgical antimicrobial prophylaxis prescribing practices and impact on infection risk: Results from a multicenter surveillance study in Italy (2012-2017)
Vicentini C.;Politano G.;Corcione S.;Furmenti M. F.;Quattrocolo F.;De Rosa F. G.;Zotti C. M.
Last
2019-01-01
Abstract
Italy is one of the largest consumers of broad-spectrum agents (BSAs) in Europe. This study evaluated surgical antimicrobial prophylaxis (SAP) compliance with the Italian national guidelines and its impact on surgical site infection (SSI) risk.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
AJIC-S-19-00261.pdf
Accesso aperto
Tipo di file:
PREPRINT (PRIMA BOZZA)
Dimensione
676.45 kB
Formato
Adobe PDF
|
676.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
